Chinese CRO forms international links
This article was originally published in Scrip
Executive Summary
Tigermed Consulting, one of China's largest pharmaceutical contract research organisations, has formed an alliance with similar firms in Russia and South Korea. It has teamed up with Saint Petersburg-based OCT and LSK in Seoul to provide services to multinational and Chinese firms looking to expand into Russia, Ukraine and eastern Europe and other Asian markets. The three CROs offer a variety of clinical development, regulatory and consulting services, and Tigermed said the network would bolster its internationalisation efforts. The Chinese venture capital group Qiming Venture Partners is among the private firm's investors.